Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Magro

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Journal of Crohn'S & Colitis|June 10, 2015
Treatment Steps, Surgery, and Hospitalization Rates During the First Year of Follow-up in Patients with Inflammatory Bowel Diseases from the 2011 ECCO-Epicom Inception CohortZ Vegh, J Burisch, N Pedersen, et al.
Journal of Crohn'S & Colitis|July 8, 2014
Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohortZ Vegh, J Burisch, N Pedersen, et al.
Alimentary Pharmacology & Therapeutics|June 7, 2018
Antigenic response to CT-P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognitionJ Goncalves, M Santos, R Acurcio, et al.
Journal of Crohn'S & Colitis|April 16, 2013
Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelinesJ Panes, Y Bouhnik, W Reinisch, et al.
Journal of Crohn'S & Colitis|January 21, 2014
Health care and patients' education in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom studyJ Burisch, Z Vegh, N Pedersen, et al.
Journal of Crohn'S & Colitis|February 25, 2014
Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with inflammatory bowel disease--an ECCO-EpiCom studyJ Burisch, P Weimers, N Pedersen, et al.
Gut|April 23, 2013
East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohortJ Burisch, N Pedersen, S Čuković-Čavka, et al.
Journal of Crohn'S & Colitis|December 10, 2013
Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe--an ECCO-EpiCom studyJ Burisch, N Pedersen, S Cukovic-Cavka, et al.
The American Journal of Gastroenterology|February 21, 2018
Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY StudyM Chaparro, A Verreth, T Lobaton, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Journal of Crohn'S & Colitis|June 10, 2015
Treatment Steps, Surgery, and Hospitalization Rates During the First Year of Follow-up in Patients with Inflammatory Bowel Diseases from the 2011 ECCO-Epicom Inception CohortZ Vegh, J Burisch, N Pedersen, et al.
Journal of Crohn'S & Colitis|July 8, 2014
Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohortZ Vegh, J Burisch, N Pedersen, et al.
Alimentary Pharmacology & Therapeutics|June 7, 2018
Antigenic response to CT-P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognitionJ Goncalves, M Santos, R Acurcio, et al.
Journal of Crohn'S & Colitis|April 16, 2013
Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelinesJ Panes, Y Bouhnik, W Reinisch, et al.
Journal of Crohn'S & Colitis|January 21, 2014
Health care and patients' education in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom studyJ Burisch, Z Vegh, N Pedersen, et al.
Journal of Crohn'S & Colitis|February 25, 2014
Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with inflammatory bowel disease--an ECCO-EpiCom studyJ Burisch, P Weimers, N Pedersen, et al.
Gut|April 23, 2013
East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohortJ Burisch, N Pedersen, S Čuković-Čavka, et al.
Journal of Crohn'S & Colitis|December 10, 2013
Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe--an ECCO-EpiCom studyJ Burisch, N Pedersen, S Cukovic-Cavka, et al.
The American Journal of Gastroenterology|February 21, 2018
Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY StudyM Chaparro, A Verreth, T Lobaton, et al.
Pageof 5